Press

Louise Liu Joins AI Panel at BioNJ BioPartnering Conference

Hill Research |
Louise Liu Joins AI Panel at BioNJ BioPartnering Conference

Hill Research CEO Dr. Louise Liu joined the panel “From Algorithm to Impact — Deploying AI in Real-World Life Sciences” at the BioNJ BioPartnering Conference, spotlighting how AI companies move beyond theory into real-world clinical, operational, and commercial impact.

The Discussion

The panel dug into what it actually takes to make AI work in practice — integrating legacy systems, managing evolving data, navigating regulatory pathways, and proving real-world value. For an AI-native CRO like Hill Research, these are the day-to-day realities of deploying agentic AI inside pharma sponsor environments for clinical trial biometrics and regulatory submissions.

Joining Dr. Liu on the panel were Richard Gearhart, Sepehr Antoine Rahimi, and moderator Corey Sanders.

About BioNJ

BioNJ is New Jersey’s life sciences trade association, with the tagline “Because Patients Can’t Wait.” The organization supports drug development and the biotech sector through advocacy, education, networking, and public policy work at the state and federal levels. The BioPartnering Conference is one of BioNJ’s signature events, convening the life sciences community for partnering, dealmaking, and discussion of industry trends.

Learn More